Company
United StatesPublic company, NASDAQ: VNDAVanda Pharmaceuticals Inc (NASDAQ: VNDA), Washington, DC – FDA Inspections
Inspection records and compliance data for Vanda Pharmaceuticals Inc in Washington, District of Columbia. 2 FDA inspections on record, last inspected March 12, 2024. Publicly traded as NASDAQ: VNDA.
Company Profile
This profile covers Vanda Pharmaceuticals Inc based in Washington, District of Columbia, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected September 9, 2019. Last inspected March 12, 2024.
Most cited issue areas
- Notification of FDA of termination of investigator1 inspection
- Reasonably foreseeable risks or discomforts1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 12, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1232759 |
| September 9, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1103014 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Vanda Pharmaceuticals Inc
Stock ticker
VNDA
Exchange
NASDAQ
Share price
$3.95
Market cap
$238.9M
Price as of
November 13, 2026
FEI Number
3006750765
Address
2200 Pennsylvania Ave Nw, Washington, District of Columbia 20037, United States
Country
United States
ID: a60e506d-9654-41ce-a906-98706debec71